|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 200 out of 377 for C5ar1

0.036s
Type Details Score
Publication
First Author: Osaka H
Year: 1999
Journal: Neuroscience
Title: Expression of C5a receptor in mouse brain: role in signal transduction and neurodegeneration.
Volume: 88
Issue: 4
Pages: 1073-82
Publication
First Author: Li Q
Year: 2010
Journal: J Am Soc Nephrol
Title: Deficiency of C5aR prolongs renal allograft survival.
Volume: 21
Issue: 8
Pages: 1344-53
Publication
First Author: Reiman R
Year: 2002
Journal: Eur J Immunol
Title: Disruption of the C5a receptor gene fails to protect against experimental allergic encephalomyelitis.
Volume: 32
Issue: 4
Pages: 1157-63
Publication
First Author: Phieler J
Year: 2013
Journal: J Immunol
Title: The complement anaphylatoxin C5a receptor contributes to obese adipose tissue inflammation and insulin resistance.
Volume: 191
Issue: 8
Pages: 4367-74
Publication
First Author: Höpken UE
Year: 1996
Journal: Nature
Title: The C5a chemoattractant receptor mediates mucosal defence to infection.
Volume: 383
Issue: 6595
Pages: 86-9
Publication  
First Author: McCullough LD
Year: 2021
Journal: J Clin Invest
Title: Exogenous inter-α inhibitor proteins prevent cell death and improve ischemic stroke outcomes in mice.
Volume: 131
Issue: 17
Publication
First Author: Mullick A
Year: 2011
Journal: PLoS One
Title: A novel role for the fifth component of complement (C5) in cardiac physiology.
Volume: 6
Issue: 8
Pages: e22919
Publication
First Author: Höpken UE
Year: 1997
Journal: J Exp Med
Title: Impaired inflammatory responses in the reverse arthus reaction through genetic deletion of the C5a receptor.
Volume: 186
Issue: 5
Pages: 749-56
Publication
First Author: Cain SA
Year: 2001
Journal: Biochem Pharmacol
Title: Modulation of ligand selectivity by mutation of the first extracellular loop of the human C5a receptor.
Volume: 61
Issue: 12
Pages: 1571-9
Publication
First Author: Shubitowski DM
Year: 2002
Journal: Cytogenet Genome Res
Title: The complement factor 5a receptor gene maps to murine chromosome 7.
Volume: 97
Issue: 1-2
Pages: 133-5
Publication
First Author: Laudes IJ
Year: 2002
Journal: J Immunol
Title: Expression and function of C5a receptor in mouse microvascular endothelial cells.
Volume: 169
Issue: 10
Pages: 5962-70
Publication
First Author: Kim AH
Year: 2004
Journal: J Immunol
Title: Complement C5a receptor is essential for the optimal generation of antiviral CD8+ T cell responses.
Volume: 173
Issue: 4
Pages: 2524-9
Publication
First Author: Zheng X
Year: 2008
Journal: Am J Pathol
Title: Gene silencing of complement C5a receptor using siRNA for preventing ischemia/reperfusion injury.
Volume: 173
Issue: 4
Pages: 973-80
Publication
First Author: Liu ZM
Year: 2010
Journal: Mol Immunol
Title: Silencing of C5a receptor gene with siRNA for protection from Gram-negative bacterial lipopolysaccharide-induced vascular permeability.
Volume: 47
Issue: 6
Pages: 1325-33
Publication
First Author: Shagdarsuren E
Year: 2010
Journal: Circulation
Title: C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice.
Volume: 122
Issue: 10
Pages: 1026-36
GXD Expression      
Probe: MGI:5642231
Assay Type: RT-PCR
Annotation Date: 2015-06-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1603911
Stage: TS11
Assay Id: MGI:5642236
Age: embryonic day 7.5
Specimen Label: 7.5dpc +
Detected: true
Specimen Num: 4
GXD Expression      
Probe: MGI:5642231
Assay Type: RT-PCR
Annotation Date: 2015-06-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1603913
Stage: TS13
Assay Id: MGI:5642236
Age: embryonic day 8.5
Specimen Label: 8.5dpc +
Detected: true
Specimen Num: 6
GXD Expression      
Probe: MGI:5642231
Assay Type: RT-PCR
Annotation Date: 2015-06-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1603915
Stage: TS15
Assay Id: MGI:5642236
Age: embryonic day 9.5
Specimen Label: 9.5dpc +
Detected: true
Specimen Num: 8
GXD Expression      
Probe: MGI:5642231
Assay Type: RT-PCR
Annotation Date: 2015-06-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1603917
Stage: TS17
Assay Id: MGI:5642236
Age: embryonic day 10.5
Specimen Label: 10.5dpc +
Detected: true
Specimen Num: 10
GXD Expression    
Probe: MGI:6154034
Assay Type: RT-PCR
Annotation Date: 2018-05-02
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1754421
Stage: TS21
Assay Id: MGI:6154227
Age: embryonic day 13.0
Image: S1
Specimen Label: E13
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:6154034
Assay Type: RT-PCR
Annotation Date: 2018-05-02
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1754422
Stage: TS22
Assay Id: MGI:6154227
Age: embryonic day 14.0
Image: S1
Specimen Label: E14
Detected: true
Specimen Num: 2
GXD Expression    
Probe: MGI:6154034
Assay Type: RT-PCR
Annotation Date: 2018-05-02
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1754424
Stage: TS24
Assay Id: MGI:6154227
Age: embryonic day 16.0
Image: S1
Specimen Label: E16
Detected: true
Specimen Num: 3
GXD Expression    
Probe: MGI:6154034
Assay Type: RT-PCR
Annotation Date: 2018-05-02
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1754426
Stage: TS26
Assay Id: MGI:6154227
Age: embryonic day 18.0
Image: S1
Specimen Label: E18
Detected: true
Specimen Num: 4
GXD Expression    
Probe: MGI:6306323
Assay Type: RT-PCR
Annotation Date: 2019-05-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1684628
Stage: TS28
Assay Id: MGI:6306327
Age: postnatal
Image: 1
Specimen Label: Liver
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:6306323
Assay Type: RT-PCR
Annotation Date: 2019-05-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1689420
Stage: TS20
Assay Id: MGI:6306327
Age: embryonic day 12.5
Image: 1
Specimen Label: Brain E12.5
Detected: true
Specimen Num: 3
GXD Expression    
Probe: MGI:6306323
Assay Type: RT-PCR
Annotation Date: 2019-05-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1689422
Stage: TS22
Assay Id: MGI:6306327
Age: embryonic day 14.5
Image: 1
Specimen Label: Brain E14.5
Detected: true
Specimen Num: 4
GXD Expression    
Probe: MGI:6306323
Assay Type: RT-PCR
Annotation Date: 2019-05-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1689424
Stage: TS24
Assay Id: MGI:6306327
Age: embryonic day 16.5
Image: 1
Specimen Label: Brain E16.5
Detected: true
Specimen Num: 5
GXD Expression    
Probe: MGI:6306323
Assay Type: RT-PCR
Annotation Date: 2019-05-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1689426
Stage: TS26
Assay Id: MGI:6306327
Age: embryonic day 18.5
Image: 1
Specimen Label: Brain E18.5
Detected: true
Specimen Num: 6
GXD Expression    
Probe: MGI:5642233
Assay Type: RNA in situ
Annotation Date: 2015-06-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1691617
Pattern: Not Specified
Stage: TS17
Assay Id: MGI:5642235
Age: embryonic day 10.5
Specimen Label: 1G
Detected: true
Specimen Num: 5
GXD Expression    
Probe: MGI:5642233
Assay Type: RNA in situ
Annotation Date: 2015-06-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1691617
Pattern: Not Specified
Stage: TS17
Assay Id: MGI:5642235
Age: embryonic day 10.5
Specimen Label: 1H
Detected: true
Specimen Num: 6
GXD Expression  
Probe: MGI:5642248
Assay Type: Immunohistochemistry
Annotation Date: 2015-07-01
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1691617
Pattern: Regionally restricted
Stage: TS17
Assay Id: MGI:5642249
Age: embryonic day 10.5
Note: Expression is in the apical surface of the neuroepithelium.
Specimen Label: 3K
Detected: true
Specimen Num: 3
GXD Expression    
Probe: MGI:5642233
Assay Type: RNA in situ
Annotation Date: 2015-06-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1614815
Pattern: Not Specified
Stage: TS15
Assay Id: MGI:5642235
Age: embryonic day 9.5
Specimen Label: 1D
Detected: true
Specimen Num: 3
GXD Expression    
Probe: MGI:5642233
Assay Type: RNA in situ
Annotation Date: 2015-06-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1614815
Pattern: Not Specified
Stage: TS15
Assay Id: MGI:5642235
Age: embryonic day 9.5
Specimen Label: 1E
Detected: true
Specimen Num: 4
GXD Expression    
Probe: MGI:5642248
Assay Type: Immunohistochemistry
Annotation Date: 2015-07-01
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1614813
Pattern: Not Specified
Stage: TS13
Assay Id: MGI:5642249
Age: embryonic day 8.5
Specimen Label: 3A
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:5642248
Assay Type: Immunohistochemistry
Annotation Date: 2015-07-01
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1614815
Pattern: Not Specified
Stage: TS15
Assay Id: MGI:5642249
Age: embryonic day 9.5
Specimen Label: 3F
Detected: true
Specimen Num: 2
GXD Expression    
Probe: MGI:5642233
Assay Type: RNA in situ
Annotation Date: 2015-06-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1697417
Pattern: Not Specified
Stage: TS17
Assay Id: MGI:5642235
Age: embryonic day 10.5
Specimen Label: 1G
Detected: true
Specimen Num: 5
GXD Expression    
Probe: MGI:5642233
Assay Type: RNA in situ
Annotation Date: 2015-06-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1697417
Pattern: Not Specified
Stage: TS17
Assay Id: MGI:5642235
Age: embryonic day 10.5
Specimen Label: 1H
Detected: true
Specimen Num: 6
GXD Expression    
Probe: MGI:5642233
Assay Type: RNA in situ
Annotation Date: 2015-06-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1614015
Pattern: Not Specified
Stage: TS15
Assay Id: MGI:5642235
Age: embryonic day 9.5
Specimen Label: 1D
Detected: true
Specimen Num: 3
GXD Expression    
Probe: MGI:5642233
Assay Type: RNA in situ
Annotation Date: 2015-06-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1614015
Pattern: Not Specified
Stage: TS15
Assay Id: MGI:5642235
Age: embryonic day 9.5
Specimen Label: 1E
Detected: true
Specimen Num: 4
GXD Expression    
Probe: MGI:5642248
Assay Type: Immunohistochemistry
Annotation Date: 2020-12-03
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1754424
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:6477354
Age: embryonic day 16.0
Specimen Label: 2B C5aR+/+
Detected: true
Specimen Num: 1
GXD Expression      
Probe: MGI:5642248
Assay Type: Immunohistochemistry
Annotation Date: 2020-12-03
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1754424
Stage: TS24
Assay Id: MGI:6477354
Age: embryonic day 16.0
Specimen Label: 2B C5aR-/-
Detected: false
Specimen Num: 2
GXD Expression    
Probe: MGI:5642233
Assay Type: RNA in situ
Annotation Date: 2015-06-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1691017
Pattern: Not Specified
Stage: TS17
Assay Id: MGI:5642235
Age: embryonic day 10.5
Specimen Label: 1G
Detected: true
Specimen Num: 5
GXD Expression    
Probe: MGI:5642233
Assay Type: RNA in situ
Annotation Date: 2015-06-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1691017
Pattern: Not Specified
Stage: TS17
Assay Id: MGI:5642235
Age: embryonic day 10.5
Specimen Label: 1H
Detected: true
Specimen Num: 6
GXD Expression    
Probe: MGI:5642233
Assay Type: RNA in situ
Annotation Date: 2015-06-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1689617
Pattern: Not Specified
Stage: TS17
Assay Id: MGI:5642235
Age: embryonic day 10.5
Specimen Label: 1G
Detected: true
Specimen Num: 5
GXD Expression    
Probe: MGI:5642233
Assay Type: RNA in situ
Annotation Date: 2015-06-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1689617
Pattern: Not Specified
Stage: TS17
Assay Id: MGI:5642235
Age: embryonic day 10.5
Specimen Label: 1H
Detected: true
Specimen Num: 6
GXD Expression    
Probe: MGI:5642233
Assay Type: RNA in situ
Annotation Date: 2015-06-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1664015
Pattern: Not Specified
Stage: TS15
Assay Id: MGI:5642235
Age: embryonic day 9.5
Specimen Label: 1D
Detected: true
Specimen Num: 3
GXD Expression    
Probe: MGI:5642233
Assay Type: RNA in situ
Annotation Date: 2015-06-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1664015
Pattern: Not Specified
Stage: TS15
Assay Id: MGI:5642235
Age: embryonic day 9.5
Specimen Label: 1E
Detected: true
Specimen Num: 4
GXD Expression    
Probe: MGI:5642233
Assay Type: RNA in situ
Annotation Date: 2015-06-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3273213
Pattern: Not Specified
Stage: TS13
Assay Id: MGI:5642235
Age: embryonic day 8.5
Specimen Label: 1A
Detected: true
Specimen Num: 1
GXD Expression  
Probe: MGI:5642233
Assay Type: RNA in situ
Annotation Date: 2015-06-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3273213
Pattern: Regionally restricted
Stage: TS13
Assay Id: MGI:5642235
Age: embryonic day 8.5
Note: Expression is in the folds, absent in the neural groove.
Specimen Label: 1B
Detected: true
Specimen Num: 2
GXD Expression    
Probe: MGI:5642233
Assay Type: RNA in situ
Annotation Date: 2015-06-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1666915
Pattern: Not Specified
Stage: TS15
Assay Id: MGI:5642235
Age: embryonic day 9.5
Specimen Label: 1D
Detected: true
Specimen Num: 3
GXD Expression    
Probe: MGI:5642233
Assay Type: RNA in situ
Annotation Date: 2015-06-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1666915
Pattern: Not Specified
Stage: TS15
Assay Id: MGI:5642235
Age: embryonic day 9.5
Specimen Label: 1E
Detected: true
Specimen Num: 4
GXD Expression    
Probe: MGI:5642233
Assay Type: RNA in situ
Annotation Date: 2015-06-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1666917
Pattern: Not Specified
Stage: TS17
Assay Id: MGI:5642235
Age: embryonic day 10.5
Specimen Label: 1G
Detected: true
Specimen Num: 5
GXD Expression    
Probe: MGI:5642233
Assay Type: RNA in situ
Annotation Date: 2015-06-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1666917
Pattern: Not Specified
Stage: TS17
Assay Id: MGI:5642235
Age: embryonic day 10.5
Specimen Label: 1H
Detected: true
Specimen Num: 6
GXD Expression
Probe: MGI:5642248
Assay Type: Immunohistochemistry
Annotation Date: 2019-05-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1754720
Pattern: Regionally restricted
Stage: TS20
Assay Id: MGI:6306324
Age: embryonic day 12.5
Image: 1A E12.5
Note: Expressed in the apical surface.
Specimen Label: 1A E12.5
Detected: true
Specimen Num: 2
GXD Expression
Probe: MGI:5642248
Assay Type: Immunohistochemistry
Annotation Date: 2019-05-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1754724
Pattern: Regionally restricted
Stage: TS24
Assay Id: MGI:6306324
Age: embryonic day 16.5
Image: 1A E16.5
Note: Expressed in the apical surface.
Specimen Label: 1A E16.5
Detected: true
Specimen Num: 3
GXD Expression
Probe: MGI:5642248
Assay Type: Immunohistochemistry
Annotation Date: 2019-05-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1754726
Pattern: Regionally restricted
Stage: TS26
Assay Id: MGI:6306324
Age: embryonic day 18.5
Image: 1A E18.5
Note: Expressed in the apical surface.
Specimen Label: 1A E18.5
Detected: true
Specimen Num: 4
GXD Expression
Probe: MGI:5642248
Assay Type: Immunohistochemistry
Annotation Date: 2019-05-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1754722
Pattern: Regionally restricted
Stage: TS22
Assay Id: MGI:6306324
Age: embryonic day 14.5
Image: 1A E14.5
Note: Expressed in the apical surface.
Specimen Label: 1A E14.5
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:5642233
Assay Type: RNA in situ
Annotation Date: 2015-06-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1654015
Pattern: Not Specified
Stage: TS15
Assay Id: MGI:5642235
Age: embryonic day 9.5
Specimen Label: 1D
Detected: true
Specimen Num: 3
GXD Expression    
Probe: MGI:5642233
Assay Type: RNA in situ
Annotation Date: 2015-06-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1654015
Pattern: Not Specified
Stage: TS15
Assay Id: MGI:5642235
Age: embryonic day 9.5
Specimen Label: 1E
Detected: true
Specimen Num: 4
Publication    
First Author: Shubitowski DM
Year: 2001
Journal: MGI Direct Data Submission
Title: Mapping of complement component 5 receptor 1
Issue: Dec
Publication  
First Author: Vaivoda R
Year: 2015
Journal: J Immunol Res
Title: CYP4F18-Deficient Neutrophils Exhibit Increased Chemotaxis to Complement Component C5a.
Volume: 2015
Pages: 250456
Publication
First Author: Grumelli S
Year: 2011
Journal: PLoS One
Title: CD46 protects against chronic obstructive pulmonary disease.
Volume: 6
Issue: 5
Pages: e18785
Publication
First Author: Bozic CR
Year: 1996
Journal: Science
Title: Neurogenic amplification of immune complex inflammation.
Volume: 273
Issue: 5282
Pages: 1722-5
Publication
First Author: Poursharifi P
Year: 2014
Journal: Mol Cell Endocrinol
Title: C5aR and C5L2 act in concert to balance immunometabolism in adipose tissue.
Volume: 382
Issue: 1
Pages: 325-33
Publication
First Author: Okinaga S
Year: 2003
Journal: Biochemistry
Title: C5L2, a nonsignaling C5A binding protein.
Volume: 42
Issue: 31
Pages: 9406-15
Publication
First Author: Kim H
Year: 2014
Journal: Infect Immun
Title: Functional roles for C5a and C5aR but not C5L2 in the pathogenesis of human and experimental cerebral malaria.
Volume: 82
Issue: 1
Pages: 371-9
Publication
First Author: Martin IV
Year: 2018
Journal: Am J Physiol Renal Physiol
Title: Complement C5a receptors C5L2 and C5aR in renal fibrosis.
Volume: 314
Issue: 1
Pages: F35-F46
Publication
First Author: Vijayan S
Year: 2014
Journal: Am J Pathol
Title: High expression of C5L2 correlates with high proinflammatory cytokine expression in advanced human atherosclerotic plaques.
Volume: 184
Issue: 7
Pages: 2123-33
Publication
First Author: Nishiura H
Year: 2009
Journal: Lab Invest
Title: Pro- and anti-apoptotic dual functions of the C5a receptor: involvement of regulator of G protein signaling 3 and extracellular signal-regulated kinase.
Volume: 89
Issue: 6
Pages: 676-94
Publication
First Author: Li R
Year: 2013
Journal: FASEB J
Title: C5L2: a controversial receptor of complement anaphylatoxin, C5a.
Volume: 27
Issue: 3
Pages: 855-64
Publication
First Author: Chehoud C
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: Complement modulates the cutaneous microbiome and inflammatory milieu.
Volume: 110
Issue: 37
Pages: 15061-6
Publication
First Author: Fonseca MI
Year: 2009
Journal: J Immunol
Title: Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease.
Volume: 183
Issue: 2
Pages: 1375-83
Publication
First Author: Seshan SV
Year: 2009
Journal: Blood
Title: Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies.
Volume: 114
Issue: 8
Pages: 1675-83
Publication
First Author: Abe T
Year: 2012
Journal: J Immunol
Title: Local complement-targeted intervention in periodontitis: proof-of-concept using a C5a receptor (CD88) antagonist.
Volume: 189
Issue: 11
Pages: 5442-8
Publication
First Author: Kim SH
Year: 2021
Journal: Cell Rep
Title: Complement C5a promotes antigen cross-presentation by Peyer's patch monocyte-derived dendritic cells and drives a protective CD8+ T cell response.
Volume: 35
Issue: 2
Pages: 108995
Publication
First Author: Markiewski MM
Year: 2009
Journal: J Immunol
Title: The regulation of liver cell survival by complement.
Volume: 182
Issue: 9
Pages: 5412-8
Publication
First Author: Ramos TN
Year: 2011
Journal: J Immunol
Title: Cutting edge: the membrane attack complex of complement is required for the development of murine experimental cerebral malaria.
Volume: 186
Issue: 12
Pages: 6657-60
Publication
First Author: Ramos TN
Year: 2009
Journal: Neurosci Lett
Title: Deletion of both the C3a and C5a receptors fails to protect against experimental autoimmune encephalomyelitis.
Volume: 467
Issue: 3
Pages: 234-6
Publication
First Author: Mueller-Ortiz SL
Year: 2017
Journal: J Immunol
Title: The Complement Anaphylatoxins C5a and C3a Suppress IFN-β Production in Response to Listeria monocytogenes by Inhibition of the Cyclic Dinucleotide-Activated Cytosolic Surveillance Pathway.
Volume: 198
Issue: 8
Pages: 3237-3244
Publication
First Author: Wang X
Year: 2011
Journal: J Clin Invest
Title: TCR-dependent transformation of mature memory phenotype T cells in mice.
Volume: 121
Issue: 10
Pages: 3834-45
Publication  
First Author: Song D
Year: 2017
Journal: Mol Vis
Title: Complement C5a receptor knockout has diminished light-induced microglia/macrophage retinal migration.
Volume: 23
Pages: 210-218
Publication
First Author: Reese B
Year: 2020
Journal: J Immunol
Title: Complement as Prognostic Biomarker and Potential Therapeutic Target in Renal Cell Carcinoma.
Volume: 205
Issue: 11
Pages: 3218-3229
Publication
First Author: Zhang C
Year: 2014
Journal: Arterioscler Thromb Vasc Biol
Title: Complement 5a receptor mediates angiotensin II-induced cardiac inflammation and remodeling.
Volume: 34
Issue: 6
Pages: 1240-8
Publication
First Author: Quell KM
Year: 2017
Journal: J Immunol
Title: Monitoring C3aR Expression Using a Floxed tdTomato-C3aR Reporter Knock-in Mouse.
Volume: 199
Issue: 2
Pages: 688-706
Publication
First Author: Zhang L
Year: 2016
Journal: J Leukoc Biol
Title: Complement anaphylatoxin receptors C3aR and C5aR are required in the pathogenesis of experimental autoimmune uveitis.
Volume: 99
Issue: 3
Pages: 447-54
Publication
First Author: Alexander JJ
Year: 2012
Journal: Kidney Int
Title: The C5a receptor has a key role in immune complex glomerulonephritis in complement factor H-deficient mice.
Volume: 82
Issue: 9
Pages: 961-8
Publication
First Author: Zhu M
Year: 2017
Journal: Diabetologia
Title: Complement C5a induces mesenchymal stem cell apoptosis during the progression of chronic diabetic complications.
Volume: 60
Issue: 9
Pages: 1822-1833
Publication
First Author: Patel SN
Year: 2008
Journal: J Exp Med
Title: C5 deficiency and C5a or C5aR blockade protects against cerebral malaria.
Volume: 205
Issue: 5
Pages: 1133-43
Publication
First Author: Lee HM
Year: 2009
Journal: Leukemia
Title: Impaired mobilization of hematopoietic stem/progenitor cells in C5-deficient mice supports the pivotal involvement of innate immunity in this process and reveals novel promobilization effects of granulocytes.
Volume: 23
Issue: 11
Pages: 2052-62
Publication
First Author: Syed SN
Year: 2018
Journal: Eur J Immunol
Title: C5aR activation in the absence of C5a: A new disease mechanism of autoimmune hemolytic anemia in mice.
Volume: 48
Issue: 4
Pages: 696-704
Publication
First Author: Borders CW
Year: 2005
Journal: Scand J Immunol
Title: Requisite role for complement C5 and the C5a receptor in granulomatous response to mycobacterial glycolipid trehalose 6,6'-dimycolate.
Volume: 62
Issue: 2
Pages: 123-30
Publication
First Author: Nunez-Cruz S
Year: 2012
Journal: Neoplasia
Title: Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization.
Volume: 14
Issue: 11
Pages: 994-1004
Publication
First Author: Heyl KA
Year: 2016
Journal: Biochem Biophys Res Commun
Title: Galectin-3 binds highly galactosylated IgG1 and is crucial for the IgG1 complex mediated inhibition of C5aReceptor induced immune responses.
Volume: 479
Issue: 1
Pages: 86-90
Publication
First Author: Liu T
Year: 2013
Journal: J Immunol
Title: An essential role for C5aR signaling in the optimal induction of a malaria-specific CD4+ T cell response by a whole-killed blood-stage vaccine.
Volume: 191
Issue: 1
Pages: 178-86
Publication
First Author: Nakayama Y
Year: 2009
Journal: J Immunol
Title: C3 promotes expansion of CD8+ and CD4+ T cells in a Listeria monocytogenes infection.
Volume: 183
Issue: 5
Pages: 2921-31
Publication
First Author: Ajona D
Year: 2017
Journal: Cancer Discov
Title: A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis.
Volume: 7
Issue: 7
Pages: 694-703
Publication
First Author: McDonald CR
Year: 2015
Journal: PLoS Pathog
Title: Experimental Malaria in Pregnancy Induces Neurocognitive Injury in Uninfected Offspring via a C5a-C5a Receptor Dependent Pathway.
Volume: 11
Issue: 9
Pages: e1005140
Publication
First Author: Bujko K
Year: 2017
Journal: Stem Cell Rev Rep
Title: Signaling of the Complement Cleavage Product Anaphylatoxin C5a Through C5aR (CD88) Contributes to Pharmacological Hematopoietic Stem Cell Mobilization.
Volume: 13
Issue: 6
Pages: 793-800
Publication
First Author: Kerr AR
Year: 2005
Journal: Infect Immun
Title: Innate immune defense against pneumococcal pneumonia requires pulmonary complement component C3.
Volume: 73
Issue: 7
Pages: 4245-52
Publication
First Author: Drouin SM
Year: 2001
Journal: J Immunol
Title: Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma.
Volume: 166
Issue: 3
Pages: 2025-32